No­vo Nordisk blue­prints new stem cell man­u­fac­tur­ing site; Clo­vis bags a BTD for Rubra­ca

→ Just a few weeks af­ter Clo­vis ex­ecs $CLVS agreed to pay more than $20 mil­lion to set­tle an SEC probe in­to the way …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland